期刊文献+

糖尿病肾病患者血清胆红素与颈动脉粥样硬化的关系 被引量:3

下载PDF
导出
摘要 目的:探讨糖尿病肾病(DKD)患者血清总胆红素(TB)、间接胆红素(IB)、直接胆红素(DB)与颈动脉粥样硬化(CAS)的关系。方法:收集2012年1月~2013年11月上海交通大学附属市第六人民医院肾内科住院的确诊为2型DN患者100例和门诊检查健康者(正常对照组)28例,将患者按GFR分为CKD3期组、CKD4期组及CKD5期组,检测各组患者血清TB、IB、DB的水平及颈动脉内膜中层厚度(CIMT),并根据CIMT值将患者分为斑块组及非斑块组,测定两组患者血清TB、IB、DB的水平。结果:DKD患者血清TB、IB、DB较正常对照组均显著减少(P〈0.05);随着GFR的下降,三组患者血清TB、IB呈显著减少(P〈0.05),但DB下降差异无统计学意义(P〉0.05);斑块组血TB、IB较非斑块组显著下降,CIMT明显升高(均P〈0.05),DB虽有下降,但差异无统计学意义(P〉0.05);Pearson直线相关分析显示DKD患者GFR与CIMT呈负相关(r=-0.506,P〈0.001),与血清TB、IB、DB呈显著正相关(r=0.542,r=0.487,r=0.333,P〈0.05);CIMT与TB、IB分别呈显著负相关(r=-0.513,r=-0.494,均P〈0.001),与DB无相关性(r=-0.205,P=0.148);非斑块组CIMT与TB、IB分别呈显著负相关(r=-0.503,r=-0.534,P〈0.05);斑块组CIMT与TB、IB分别呈显著负相关(r=-0.477,r=-0.518,P〈0.05)。结论:DKD患者血清胆红素水平的测定,尤其是血清TB与IB的水平高低可预测CAS的发生及严重程度,测定血清胆红素水平对防治DKD患者心血管事件的早期发生具有重要意义。
出处 《中国中西医结合肾病杂志》 2015年第7期601-603,共3页 Chinese Journal of Integrated Traditional and Western Nephrology
  • 相关文献

参考文献9

  • 1Zhuo L, Zou G, Li W, et al. Prevalence of diabeticnephropathy complicating non - diabetic renal disease among Chinese pa- tients with type 2 diabetes meUitus. Eur J Med Res,2013,18 (I):4.
  • 2Zheng J, Inoguehi T, Sasaki S, et al. Phyeoeyanin and phycoeya- nobilin from spirulina platensis protect against diabetic nephropa- thy by inhibiting oxidative stress. Am J Physiol Regul Integr Comp Physio1,2013,304 (2) : R110 - R120.
  • 3Mookadam F, Tanasunont W, Jalal U, et al. Carotid intima -media thickness and cardiovascular risk. Future Cardio, 2011,7 (2) :173 - 182.
  • 4Xu Y,Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA,2013,310 (9) :948 - 959.
  • 5Foucher C, Brugbre L, Ansquer JC. Fenofibrate, homoeysteine and renal function. Curr Vase Pharmaeo1,2010,8 ( 5 ) :589 - 603.
  • 6Kawamura K, Ishikawa K, Wada Y, et al. Bilirubin from heme ox- ygenase- 1 attenuates vascular endothelial activation and dys- function. Arterioscler Thromb Vase Biol, 2005,25 ( 1 ) : 155 - 160.
  • 7Dekker D, Dorresteijn MJ, Pijnenburg M, et al. The bilirubin - in- creasing drug atazanavir improves endothelial function in patients with type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol, 2011,31 (2) :458 -463.
  • 8Florczyk UM, Jozkowicz A, Dulak J. Biliverdin reductase: new features of an old enzyme and its potential therapeutic signifi- cance. Pharmacol Rep,2008,60( 1 ) :38 -48.
  • 9王国华,章旭,曹娟,李海涛,印荻,周长菊,丁浩,许琴.慢性肾病患者颈动脉粥样硬化的临床分析[J].江苏医药,2012,38(5):558-560. 被引量:3

二级参考文献8

  • 1刘俊,余月明,周华.慢性肾衰竭患者颈动脉斑块形成与脑梗死的关系[J].中国血液净化,2005,4(1):34-34. 被引量:2
  • 2王海燕,王梅,左力,等.慢性肾脏病及透析的临床实践指南Ⅰ[M].北京:人民卫生出版社,2003:36-57.
  • 3Yilmaz MI,Qureshi AR,Carrero JJ,et al.Predictors of carotidartery intima-media thickness in chronic kidney disease andkidney transplant patients without overt cardiovascular disease[J].Am J Nephrol,2010,31(3):214-221.
  • 4Kawamoto R,Ohtsuka N,Kusunoki T,et al.An associationbetween the estimated glomerular filtration rate and carotidatherosclerosis[J].Intern Med,2008,47(5):391-398.
  • 5Kastarinen H,Ukkola O,Kesniemi YA.Glomerular filtrationrate is related to carotid intima-media thickness in middle-agedadults[J].Nephrol Dial Transplant,2009,24(9):2767-2772.
  • 6Ito H,Komatsu Y,Mifune M,et al.The estimated GFR,butnot the stage of diabetic nephropathy graded by the urinaryalbumin excretion,is associated with the carotid intima-mediathickness in patients with type 2diabetes mellitus:a cross-sectional study[J].Cardiovasc Diabetol,2010,15(9):18.
  • 7Szeto CC,Chow KM,Woo KS,et al.Carotid intima mediathickness predicts cardiovascular diseases in Chinese predialysispatients with chronic kidney disease[J].J Am Soc Nephrol,2007,18(6):1966-1972.
  • 8彭世义.超声检测2型糖尿病患者颈动脉流体动力学和管壁生理学指标的意义[J].江苏医药,2011,37(12):1459-1461. 被引量:2

共引文献2

同被引文献39

  • 1曹霞,谢秀梅,徐果,袁洪,陈志恒.长沙市体检人群正常高值血压与慢性肾疾病的横断面研究[J].中南大学学报(医学版),2014,39(6):582-590. 被引量:9
  • 2Chang JM, Kuo MC, Kuo HT, et al. Increased glomerular and ex- tracellular malondialdehyde levels in patients and rats with dia- betic nephropathy. Journal of Laboratory and Clinical Medicine, 2005,146(4) :210 -215.
  • 3Descamps - Latscha B, Witko - Sarsat V, Ngnyen - Khoa T, et al. Early prediction of IgA nephropathy progression: proteinuria and AOPP are strong prognostic markers. Kidney international, 2004,66(4) :1606 - 1612.
  • 4Ryter SW, Choi AMK. Heme oxygenase -1/carbon monoxide: from metabolism to molecular therapy. American Journal of Re- spiratory Cell and Molecular Biology,2009,41 ( 3 ) : 251 - 260.
  • 5Lee MJ,Jung CH,Kang YM,et al. Serum bilirubin as a predictor of incident metabolic syndrome : A 4 - year retrospective longitu- dinal study of 6205 initially healthy Korean men. Diabetes & Me- tabolism,2014,40(4) :305 -309.
  • 6Riphagen IJ, Deetman PE, Bakker SJ, et al. Bilirubin and pro- gression of nephropathy in type 2 diabetes : a post - hoc analysis of RENAAL with independent replication in IDNT. Diabetes, 2014,63 (8) :2845 - 2853.
  • 7Tanaka M, Fukui M, Okada H, et al. Low serum bilirubin concen- tration is a predictor of chronic kidney disease. Atheroselerosis, 2014,234(2) :421 -425.
  • 8Dounousi E, Papavasiliou E, Makedou A, et al. Oxidative stress is progressively enhanced with advancing stages of CKD. American Journal of Kidney Diseases ,2006,48 (5) :752 - 760.
  • 9Terawaki H, Yoshimura K, Hasegawa T, et al. Oxidative stress is enhanced in correlation with renal dysfunction:examination with the redox state of albumin. Kidney Int, 2004,66 ( 5 ) : 1988 - 1993.
  • 10Vitek L. The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases. Front Pharmacol, 2012,3 : 55.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部